Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
Europe
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Copper(ii) Chloride
2. Cucl2
3. Cupric Chloride Anhydrous
4. Cupric Chloride Dihydrate
5. Cupric Chloride Eriochalcite (cucl2.2h2o)
6. Cupric Chloride, 64cu-labeled Cpd
7. Cupric Chloride, Dihydrate 2h-labeled Cpd
1. Copper(ii) Chloride
2. Copper Chloride
3. 7447-39-4
4. Cupric Chloride Anhydrous
5. Copper Dichloride
6. Copper Bichloride
7. Cupric Dichloride
8. Copper(2+) Chloride
9. Cucl2
10. Copper Chloride (cucl2)
11. Dichlorocopper
12. Copper(2+)chloride
13. Copper (ii) Chloride
14. Copper(ii) Chloride (1:2)
15. Coclor
16. Copper(ii)chloride
17. Copper(ii) Chloride, Anhydrous
18. Chebi:49553
19. Mfcd00010972
20. Nsc165706
21. Copper Chloride (van)
22. Ccris 6883
23. Hsdb 259
24. Cupric Chloride In Plastic Container
25. Einecs 231-210-2
26. Copper (ii)chloride
27. Copper(ii)-chloride
28. Copper (ii) Cloride
29. Nsc 165706
30. Copper (ii)-chloride
31. Ai3-01658
32. Epitope Id:156811
33. Copper(ii) Chloride, 97%
34. Copper (ii) Chloride, 95%
35. Copper(ii) Chloride, Ultra Dry
36. Unii-p484053j2y
37. Copper(ii) Chloride, Powder, 99%
38. Copper(ii) Chloride, P.a., 97%
39. Copper(ii) Chloride, Lr, >=98%
40. Akos015902778
41. Db09131
42. Bp-13443
43. Nci60_001274
44. Copper (ii) Chloride, Trace Metals Grade
45. Ft-0624119
46. Ec 231-210-2
47. Copper(ii) Chloride, Saj First Grade, >=98.0%
48. Q421781
49. Copper(ii) Chloride, 99.999% Trace Metals Basis
50. Copper(ii) Chloride, Anhydrous, Powder, >=99.995% Trace Metals Basis
51. Copper (ii) Chloride, Ultra Dry, Powder, Ampoule, 99.995% Trace Metals Grade
52. Copper Atomic Spectroscopy Standard Concentrate 1.00 G Cu, 1.00 G/l, For 1l Standard Solution, Analytical Standard
Molecular Weight | 134.45 g/mol |
---|---|
Molecular Formula | Cl2Cu |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 0 |
Rotatable Bond Count | 0 |
Exact Mass | 132.867303 g/mol |
Monoisotopic Mass | 132.867303 g/mol |
Topological Polar Surface Area | 0 Ų |
Heavy Atom Count | 3 |
Formal Charge | 0 |
Complexity | 2.8 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 2 | |
---|---|
Drug Name | Cupric chloride in plastic container |
Active Ingredient | Cupric chloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 0.4mg copper/ml |
Market Status | Prescription |
Company | Hospira |
2 of 2 | |
---|---|
Drug Name | Cupric chloride in plastic container |
Active Ingredient | Cupric chloride |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 0.4mg copper/ml |
Market Status | Prescription |
Company | Hospira |
For use as a supplement to intravenous solutions given for total parenteral nutrition (TPN).
Copper is an essential nutrient which serves as a co factor for serum ceruloplasmin, an oxidase necessary for proper formation of the iron carrier protein, transferrin. Copper also helps maintain normal rates of red and white blood cell formation. Providing copper during Total Parenteral Nutrition helps prevent development of the following deficiency symptoms: Leukopenia, neutropenia, anemia, depressed ceruloplasmin levels, impaired transferrin formation, secondary iron deficiency and osteoporosis.
Absorption
Mean copper absorption of 57 percent (range 40 to 70 per cent) following oral administration of 0.4 - 4.5 mg copper (as copper acetate) to four volunteers. An early human study suggested a maximum blood copper concentration was reached some two hours after oral copper chloride administration (1.5 - 12 mg copper)
Route of Elimination
Renal
Volume of Distribution
Copper is distributed to all tissues with the highest concentrations in liver, heart, brain, kidneys and muscle. Intracellular copper is predominantly metallothionein-bound. Reported copper in the lungs, liver, kidney, blood, bile and stomach (33.7, 35.1, 41.4, 13.8, 2.8, and 2988 g/g wet weight respectively)
ICR male mice aged 5 weeks were injected subcutaneously with cadmium chloride, lead acetate, silver nitrate, cupric chloride, a combination of cadmium and silver compounds, or a combination of copper and silver compounds. These injections were carried out 3 times. Twenty four hours after the last injection, they were sacrificed. Cadmium injection significantly stimulated serum ceruloplasmin activity and copper concentration, accompanied by an increase in hepatic copper. Lead injection also slightly increased the serum ceruloplasmin level. In contrast, silver injection markedly decreased both serum ceruloplasmin activity and copper concentration in the serum. Hepatic copper increased slightly after silver injection. The copper injection stimulated copper binding to metallothionein and bile excretion of copper, but not serum ceruloplasmin release. With a copper and silver combination, the effect of silver on serum ceruloplasmin was lost, with a concomitant disappearance of silver from the serum ceruloplasmin fraction in the serum. In the mouse, cadmium and silver, copper antagonistic metals, influence different sites of serum ceruloplasmin metabolism. Excess hepatic copper is partly eliminated by excretion of bile and is partly detoxified by metallothionein induction.
PMID:3606389 Sugawara N, Sugaware C; Arch Toxicol 59 (6): 432-36 (1987)
The in vitro interaction of organic copper compounds with rat liver glutathione S-transferases was studied with reduced glutathione and 1-chloro-2,4-dinitrobenzene as substrates. Both organic and inorganic copper are spontaneously conjugated with glutathione, but interact with glutathione S-transferase by direct binding to these proteins.
The in vitro interaction of organic copper compounds with rat liver glutathione S-transferases was studied with reduced glutathione and 1-chloro-2,4-dinitrobenzene as substrates. Both organic and inorganic copper are spontaneously conjugated with glutathione, but interact with glutathione S-transferase by direct binding to these proteins.
PMID:3008276 Dierickx PJ; Res Commun Chem Pathol Pharmacol 51 (2): 285-88 (1986)
Related Excipient Companies
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Copper Chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Copper Chloride, including repackagers and relabelers. The FDA regulates Copper Chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Copper Chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Copper Chloride supplier is an individual or a company that provides Copper Chloride active pharmaceutical ingredient (API) or Copper Chloride finished formulations upon request. The Copper Chloride suppliers may include Copper Chloride API manufacturers, exporters, distributors and traders.
click here to find a list of Copper Chloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Copper Chloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Copper Chloride active pharmaceutical ingredient (API) in detail. Different forms of Copper Chloride DMFs exist exist since differing nations have different regulations, such as Copper Chloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Copper Chloride DMF submitted to regulatory agencies in the US is known as a USDMF. Copper Chloride USDMF includes data on Copper Chloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Copper Chloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Copper Chloride suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Copper Chloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Copper Chloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Copper Chloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Copper Chloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Copper Chloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Copper Chloride suppliers with NDC on PharmaCompass.
Copper Chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Copper Chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Copper Chloride GMP manufacturer or Copper Chloride GMP API supplier for your needs.
A Copper Chloride CoA (Certificate of Analysis) is a formal document that attests to Copper Chloride's compliance with Copper Chloride specifications and serves as a tool for batch-level quality control.
Copper Chloride CoA mostly includes findings from lab analyses of a specific batch. For each Copper Chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Copper Chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Copper Chloride EP), Copper Chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Copper Chloride USP).
LOOKING FOR A SUPPLIER?